19 Dec '11, 4am
Johnson & Johnson Denying Poor People Access to Critical AIDS Drugs | Care2 Causes
Every hour, around 30 children die of AIDS. On its corporate website, Johnson & Johnson makes a big deal about its “Giving in HIV/AIDS,” claiming to “work to prevent the spread of HIV and reduce the burden of AIDS on women and their families.” However, the Stop AIDS Campaign tells a different story. Johnson & Johnson is one of the few major pharmaceutical companies that is still refusing to negotiate with the Medicines Patent Pool to ensure that people waiting for life-saving HIV medicines can access them. Since Johnson & Johnson holds patents for some of the most vital and costly HIV drugs, their refusal to enter negotiations with the pool effectively cuts off access to these drugs for those who need it the most.